ArticleCardiovascular diabetology2023

The real-world safety profile of sodium-glucose co-transporter-2 inhibitors among older adults (≥ 75 years): a retrospective, pharmacovigilance study.

Adam Goldman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.